RecruitingNot Applicable

Harm Reduction Services

United States200 participantsStarted 2024-11-25

Plain-language summary

The purpose of this study is to assess whether an integrated harm reduction intervention (IHRI), compared to harm reduction (HR) services as usual, will improve harm reduction service utilization among Black and Latinx people who use drugs (PWUD).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * at least 18 years of age * self-identified as misusing opioids +/- other substances (stimulants) in the past 30 days, confirmed by interview using DSM-5 criteria * English or Spanish speaking * able to provide informed consent. Exclusion Criteria: * inability to provide informed consent or participate in the study procedures as proposed in the consent * active suicidal or homicidal ideation or an unstable psychotic disorder (schizophrenia, schizoaffective disorder) or mood disorder (bipolar disorder, severe major depressive disorder) * an unwillingness to be randomized. * are prisoners

What they're measuring

Percentage of Participants who Attend At least 1 Harm Reduction (HR) Session after Introductory HR Session

Timeframe: Up to Week 8

Percentage of Participants who Attend at least 3 HR Sessions in Total

Timeframe: Up to Week 8

Trial details

NCT IDNCT05776316

SponsorNYU Langone Health

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-09-29

Contact for this trial

Ayana Jordan, MD, PhD

(203) 787-8032 Ayana.Jordan@nyulangone.org

View on ClinicalTrials.gov More Drug Use trials